Sales decline 20.74% to Rs 101.95 crore Net profit of Neuland Laboratories declined 71.89% to Rs 1.92 crore in the quarter ended December 2014 as against Rs 6.83 crore during the previous quarter ended December 2013. Sales declined 20.74% to Rs 101.95 crore ... Business Standard, 4 weeks ago
Neuland to invest Rs. 300-cr in next 4 years to double its revenues - PharmaBiz, 1 month ago
1 images for "neuland laboratories"
Neuland Laboratories Limited has informed the Exchange that Export Import Bank of India ( EXIM Bank ) has withdrawn the nomination of Mr.Nadeem Panjetan as a Director on the Board of Company , w.e.f. December 8, 2014 . Consequently, Mr. Nadeem ...4 Traders, 2 months ago NEULAND LABORATORIES : EXIM Bank withdraws nominee director from Neuland Laboratories Ltd 4 Traders, 2 months ago EXIM Bank withdraws nomination of Nadeem Panjetan as director of Neuland Laboratories Money Control, 2 months ago Neuland Laboratories allots equity shares on rights basis Money Control, 2 months ago
By a News Reporter-Staff News Editor at Biotech Week -- Neuland Laboratories Ltd. , (NSE: NEULANDLAB; BSE-Scrip Code: 524558), a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and custom ...4 Traders, 3 weeks ago Neuland Labs' revenues for third quarter of FY 2015 decrease 17% to $17.14 million News-Medical.Net, 4 weeks ago Neuland Labs Reports Third Quarter Fiscal Year 2015 Financial Results RCL Advisors, 4 weeks ago Neuland Labs Reports Another Successful FDA Audit And Wins 2015 CMO Leadership Award TickerTech.com, 1 month ago
On 30 January 2015Business Standard, 1 month ago Neuland Laboratories Ltd to consider Q3 results on Jan 30, 2015 Equity Bulls, 1 month ago
News Top News Top Story India Infoline News Service | Mumbai | February 02, 2015 14:19 IST The counter has witnessed heavy selling after company reported poor quarterly earnings. ...India Infoline, 3 weeks ago
Indian regulatory system needs to be strengthened to improve clinical trial industry in India: Neuland labs CFO
As the clinical trial industry is facing lot of resistance in India, Industry experts are of the view that the Indian regulatory system should undergo massive reforms to contain unethical practices in clinical trials and should pave way to open up ...PharmaBiz, 2 months ago
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have HCL Technologies, Bajaj Auto, GNFC, EID Parry, Neuland Laboratories, Heritage Foods, Monsanto, Future Retail and IDFC.Money Control, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!